Literature DB >> 2628864

Immunomodulatory effects of Bacteroides products on in vitro human lymphocyte functions.

B J Shenker, J Slots.   

Abstract

Bacteroides spp. have been implicated in the pathogenesis of several diseases, including periodontal diseases. In this study sonic extracts of 6 Bacteroides spp. were examined for their abilities to alter human lymphocyte function. We found that soluble extracts from Bacteroides intermedius, Bacteroides endodontalis, Bacteroides asaccharolyticus, Bacteroides melaninogenicus, and to a lesser degree Bacteroides loescheii, caused dose-dependent inhibition of human lymphocyte responsiveness to both mitogens and antigens. Suppression involved altered DNA, RNA and protein synthesis as well as immunoglobulin production. In contrast, Bacteroides gingivalis did not suppress these responses; instead, it stimulated lymphocyte proliferation and enhanced immunoglobulin production. It has been proposed that impaired host defense may play a pivotal role in the pathogenesis of many infections. The data presented in this paper suggest that microbial mediated immunosuppression may conceivably alter the nature and consequences of host-parasite interactions in periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2628864     DOI: 10.1111/j.1399-302x.1989.tb00402.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  3 in total

1.  Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells.

Authors:  B J Shenker; L A Vitale; D A Welham
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Immunosuppressive effects of Prevotella intermedia on in vitro human lymphocyte activation.

Authors:  B J Shenker; L Vitale; J Slots
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

3.  Hemoglobin binding activity and hemoglobin-binding protein of Prevotella nigrescens.

Authors:  M Miyashita; S Oishi; A Kiso; Y Kikuchi; O Ueda; K Hirai; Y Shibata; Setsuo Fujimura
Journal:  Eur J Med Res       Date:  2010       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.